Phibro Animal Health Corporation PAHC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.54B | 1.52B | 1.50B | 1.46B | 1.40B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.54B | 1.52B | 1.50B | 1.46B | 1.40B |
| Cost of Revenue | 1.03B | 1.01B | 1.01B | 987.51M | 952.85M |
| Gross Profit | 513.61M | 505.97M | 492.42M | 476.82M | 446.83M |
| SG&A Expenses | 315.47M | 309.33M | 299.12M | 289.60M | 278.18M |
| Depreciation & Amortization | 2.40M | 2.40M | 2.38M | 2.38M | 2.38M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.35B | 1.32B | 1.31B | 1.28B | 1.23B |
| Operating Income | 195.74M | 194.24M | 190.92M | 184.84M | 166.27M |
| Income Before Tax | 139.86M | 137.35M | 128.85M | 126.23M | 94.64M |
| Income Tax Expenses | 37.14M | 37.63M | 33.62M | 34.14M | 26.82M |
| Earnings from Continuing Operations | 102.71 | 99.72 | 95.23 | 92.09 | 67.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 102.71M | 99.72M | 95.23M | 92.09M | 67.82M |
| EBIT | 195.74M | 194.24M | 190.92M | 184.84M | 166.27M |
| EBITDA | 246.48M | 244.23M | 240.08M | 234.17M | 214.28M |
| EPS Basic | 2.53 | 2.46 | 2.35 | 2.27 | 1.67 |
| Normalized Basic EPS | 2.20 | 2.11 | 2.16 | 2.19 | 1.80 |
| EPS Diluted | 2.51 | 2.44 | 2.34 | 2.26 | 1.66 |
| Normalized Diluted EPS | 2.18 | 2.09 | 2.14 | 2.18 | 1.79 |
| Average Basic Shares Outstanding | 162.27M | 162.22M | 162.12M | 162.09M | 162.06M |
| Average Diluted Shares Outstanding | 163.95M | 163.87M | 163.57M | 163.24M | 163.00M |
| Dividend Per Share | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
| Payout Ratio | 18.96% | 19.52% | 20.43% | 21.13% | 28.69% |